Cargando…
eEF2K Inhibitor Design: The Progression of Exemplary Structure-Based Drug Design
The α-kinase, eEF2K, phosphorylates the threonine 56 residue of eEF2 to inhibit global peptide elongation (protein translation). As a master regulator of protein synthesis, in combination with its unique atypical kinase active site, investigations into the targeting of eEF2K represents a case of int...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9921739/ https://www.ncbi.nlm.nih.gov/pubmed/36770760 http://dx.doi.org/10.3390/molecules28031095 |